AAAAAA
Results:
1-11
|
Results: 11
Authors:
Boogaerts, M
Maertens, J
van Hoof, A
de Bock, R
Fillet, G
Peetermans, M
Selleslag, D
Vandercam, B
Vandewoude, K
Zachee, P
De Beule, K
Citation: M. Boogaerts et al., Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients, J ANTIMICRO, 48(1), 2001, pp. 97-103
Authors:
Vandercam, B
Gerain, J
Humblet, Y
Ferrant, A
Wauters, G
Moreau, M
Longueville, J
Symann, M
Straetmans, N
Citation: B. Vandercam et al., Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients, ANN HEMATOL, 79(3), 2000, pp. 152-157
Authors:
Frippiat, F
Derue, G
Heller, F
Honore, P
Moreau, M
Vandercam, B
Citation: F. Frippiat et al., Acute pancreatitis associated with severe lactic acidosis in human immunodeficiency virus-infected patients receiving triple therapy, J ANTIMICRO, 45(3), 2000, pp. 411-412
Authors:
Hermans, BP
Materne, R
Marot, JC
Vandercam, B
Van Beers, BE
Van Cangh, PJ
Citation: Bp. Hermans et al., Indinavir calculi: Diagnosis with magnetic resonance urography, EUR UROL, 37(5), 2000, pp. 634-635
Authors:
Samani, KK
Vandercam, B
Straetmans, N
Michaux, L
Ferrant, A
Citation: Kk. Samani et al., Penicillin or vancomycin plus ceftazidime in febrile neutropenic patients after stem cell transplantation, ACT CLIN B, 55(5), 2000, pp. 279-284
Authors:
Viscoli, C
Girmenia, C
Marinus, A
Collette, L
Martino, P
Vandercam, B
Doyen, C
Lebeau, B
Spence, D
Krcmery, V
De Pauw, B
Meunier, F
Citation: C. Viscoli et al., Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC), CLIN INF D, 28(5), 1999, pp. 1071-1079
Authors:
Vannuffel, P
Heusterspreute, M
Bouyer, M
Vandercam, B
Philippe, M
Gala, JL
Citation: P. Vannuffel et al., Molecular characterization of femA from Staphylococcus hominis and Staphylococcus saprophyticus, and femA-based discrimination of staphylococcal species, RES MICROB, 150(2), 1999, pp. 129-141
Authors:
Colebunders, R
Clumeck, N
Florence, E
Vandercam, B
Van Wanzeele, F
Van Wijngaerden, E
Lacor, P
Demonty, J
De Wit, S
Citation: R. Colebunders et al., Safe and effective use of combination antiretroviral treatment, ACT CLIN B, 54(2), 1999, pp. 55-60
Authors:
Colardijn, F
Damas, P
De Mol, P
Glupczynski, Y
Gordus, B
Ronveaux, O
Struelens, M
Thys, JP
Verhaegen, J
Vogelaers, D
Wilmotte, L
Bossens, M
Byl, B
Carpentier, M
Claeys, G
Crokaert, F
Daux, J
Dediste, A
De Jongh, D
Delporte, JP
Desmet, F
d'Hollander, A
Ezzedine, H
Fameree, D
Garrino, M
Goossens, H
Govaerts, D
Hecq, JD
Ieven, G
Jacobs, F
Jordens, P
Larbuisson, W
Laterre, PF
Lauwers, S
Lefebure, B
Lievin, V
Meert, P
Melin, P
Mertens, A
Moulin, D
Peetermans, W
Peleman, R
Potvliege, C
Reynaert, M
Rost, F
Simon, A
Sion, JP
Stuyck, J
Valcke, Y
Van Beek, F
Vandercam, B
Van Laethem, Y
Van Landuyt, H
Van Vooren, JP
Van Wyngaarden, E
Verbist, L
Verschraegen, G
Vincent, JL
Wauters, G
Willems, L
Citation: F. Colardijn et al., GDEPIH-GOSPIZ Belgian consensus strategies to control antibiotic-resistantbacteria in hospitals, ACT CLIN B, 54(1), 1999, pp. 15-16
Authors:
Ellis, M
Spence, D
de Pauw, B
Meunier, F
Marinus, A
Collette, L
Sylvester, R
Meis, J
Boogaerts, M
Selleslag, D
Kremery, V
von Sinner, W
MacDonald, P
Doyen, C
Vandercam, B
Citation: M. Ellis et al., An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis, CLIN INF D, 27(6), 1998, pp. 1406-1412
Authors:
Bolla, G
Lambert, M
Boscagli, A
Frippiat, F
Vandercam, B
Montagne, N
Puchois, A
Citation: G. Bolla et al., Erythema nodosum and chronic myelomonocytic leukemia: two cases, REV MED IN, 19(11), 1998, pp. 838-839
Risultati:
1-11
|